Tears as a source of biomarkers for ocular and systemic diseases

Experimental Eye Research

Volumn 117, Issue , 2013, Pages 126-137

  von Thun und Hohenstein Blaul, Nadine ^a   Funke, Sebastian ^a   Grus, Franz H ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Biomarker; Dry eye; Ocular disease; Protein profile; Proteomics; Systemic disease; Tear fluid

Indexed keywords

BIOLOGICAL MARKER; TEAR PROTEIN;

DIABETIC RETINOPATHY; EYE DISEASE; GLAUCOMA; HUMAN; LACRIMAL FLUID; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SYSTEMIC DISEASE; TREATMENT RESPONSE;

BIOMARKER; DRY EYE; OCULAR DISEASE; PROTEIN PROFILE; PROTEOMICS; SYSTEMIC DISEASE; TEAR FLUID;

BIOLOGICAL MARKERS; DRY EYE SYNDROMES; EYE DISEASES; EYE PROTEINS; HUMANS; PROTEOMICS; TEARS;

EID: 84888128535     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.07.015     Document Type: Review

References (168)

1. Alberghina D., Giannetto C., Vazzana I., Ferrantelli V., Piccione G. Reference intervals for total protein concentration, serum protein fractions, and albumin/globulin ratios in clinically healthy dairy cows. J.Vet. Diagn. Invest. 2011, 23:111-114.
2. Aluru S.V., Agarwal S., Srinivasan B., Iyer G.K., Rajappa S.M., Tatu U., Padmanabhan P., Subramanian N., Narayanasamy A. Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome. PLoS One 2012, 7:e51979.
3. Ananthi S., Santhosh R.S., Nila M.V., Prajna N.V., Lalitha P., Dharmalingam K. Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp. Eye Res. 2011, 92:454-463.
4. Annesley T.M. Ion suppression in mass spectrometry. Clin. Chem. 2003, 49:1041-1044.
5. Avery M.J. Quantitative characterization of differential ion suppression on liquid chromatography/atmospheric pressure ionization mass spectrometric bioanalytical methods. Rapid Commun. Mass Spectrom. 2003, 17:197-201.
6. Baier G., Wollensak G., Mur E., Redl B., Stoffler G., Gottinger W. Analysis of human tear proteins by different high-performance liquid chromatographic techniques. J.Chromatogr. 1990, 525:319-328.
7. Balasubramanian S.A., Pye D.C., Willcox M.D. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp. Eye Res. 2012, 96:132-137.
8. Barbulovic-Nad I., Lucente M., Sun Y., Zhang M., Wheeler A.R., Bussmann M. Bio-microarray fabrication techniques-a review. Crit. Rev. Biotechnol. 2006, 26:237-259.
9. Barka T., Asbell P.A., van der Noen H., Prasad A. Cystatins in human tear fluid. Curr. Eye Res. 1991, 10:25-34.
10. Bell K., Gramlich O.W., Von Thun Und Hohenstein-Blaul N., Beck S., Funke S., Wilding C., Pfeiffer N., Grus F.H. Does autoimmunity play a part in the pathogenesis of glaucoma?. Prog. Retin. Eye Res. 2013 Mar 27, (Epub ahead of print). 10.1016/j.preteyeres.2013.02.003.
11. Beuerman R.W., Zhou L. Biomarkers and proteomics in corneal cell Biology. Acta Ophthalmologica 2011, 89:0.
12. Bodnar W.M., Blackburn R.K., Krise J.M., Moseley M.A. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J.Am. Soc. Mass Spectrom. 2003, 14:971-979.
13. Boehm N., Funke S., Wiegand M., Wehrwein N., Pfeiffer N., Grus F.H. Alterations in the tear proteome of dry eye patients-a matter of the clinical phenotype. Invest. Ophthalmol. Vis. Sci. 2013, 54:2385-2392.
14. Boehm N., Riechardt A.I., Wiegand M., Pfeiffer N., Grus F.H. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2011, 52:7725-7730.
15. Boehm N., Wolters D., Thiel U., Lossbrand U., Wiegel N., Pfeiffer N., Grus F.H. New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study. Brain Behav. Immun. 2012, 26:96-102.
16. Bohm D., Keller K., Pieter J., Boehm N., Wolters D., Siggelkow W., Lebrecht A., Schmidt M., Kolbl H., Pfeiffer N., Grus F.H. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol. Rep. 2012, 28:429-438.
17. Bours J., Reitz C., Strobel J., Breipohl W. Detection of secretory IgM in tears during rhino-conjunctivitis. Graefes Arch. Clin. Exp. Ophthalmol. 2005, 243:456-463.
18. Brauninger G.E., Centifanto Y.M. Immunoglobulin E in human tears. Am. J. Ophthalmol. 1971, 72:558-561.
19. Broekhuyse R.M. Tear lactoferrin: a bacteriostatic and complexing protein. Invest. Ophthalmol. 1974, 13:550-554.
20. Chong R.S., Jiang Y.Z., Boey P.Y., Yu S.J., Htoon H.M., Aung T., Khaw P.T., Wong T.T. Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome. Ophthalmology 2010, 117:2353-2358.
21. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr. Opin. Immunol. 1995, 7:812-818.
22. Coyle P.K., Sibony P.A. Tear immunoglobulins measured by ELISA. Invest. Ophthalmol. Vis. Sci. 1986, 27:622-625.
23. Dams R., Huestis M.A., Lambert W.E., Murphy C.M. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J.Am. Soc. Mass Spectrom. 2003, 14:1290-1294.
24. Dartt D.A. Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion. Exp. Eye Res. 2004, 78:337-345.
25. Dawson L., Tobin A., Smith P., Gordon T. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?. Arthritis Rheum. 2005, 52:2984-2995.
26. Dawson L.J., Stanbury J., Venn N., Hasdimir B., Rogers S.N., Smith P.M. Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006, 54:1165-1173.
27. de Freitas Campos C., Cole N., Van Dyk D., Walsh B.J., Diakos P., Almeida D., Torrecilhas A., Laus J.L., Willcox M.D. Proteomic analysis of dog tears for potential cancer markers. Res. Vet. Sci. 2008, 85:349-352.
28. de Souza G.A., Godoy L.M., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7:R72.
29. Delahunty C.M., Yates J.R. MudPIT: multidimensional protein identification technology. Biotechniques 2007, 43. pp. 563, 565, 567 passim.
30. DEWS The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007, 5:75-92.
31. Engwegen J.Y., Gast M.C., Schellens J.H., Beijnen J.H. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 2006, 27:251-259.
32. Eule C., Jurk S., Boehm N., Grus F. Tear protein pattern detected via MALDI-TOF in healthy dogs and in dogs with keratoconjunctivitis sicca (KCS). Invest. Ophthalmol. Vis. Sci. 2009, 50:2607.
33. Evans J.E., Green K.M., Sullivan R.M., Schaumberg D.A., Dana M.R., Sullivan D.A. Proteomic analysis of human meibomian gland secretions. Invest. Ophthalmol. Vis. Sci. 2003, 44:2478.
34. Evans V., Vockler C., Friedlander M., Walsh B., Willcox M.D. Lacryglobin in human tears, a potential marker for cancer. Clin. Exp. Ophthalmol. 2001, 29:161-163.
35. Fang Y., Frutos A.G., Lahiri J. Membrane protein microarrays. J.Am. Chem. Soc. 2002, 124:2394-2395.
36. Fullard R.J. Identification of proteins in small tear volumes with and without size exclusion HPLC fractionation. Curr. Eye Res. 1988, 7:163-179.
37. Fung K.Y., Morris C., Sathe S., Sack R., Duncan M.W. Characterization of the invivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Proteomics 2004, 4:3953-3959.
38. Funke S., Azimi D., Wolters D., Grus F.H., Pfeiffer N. Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RP-Capillary-HPLC-MALDI TOF/TOF MS approach. J.Proteomics 2012, 75:3177-3190.
39. Gachon A.M., Richard J., Dastugue B. Human tears: normal protein pattern and individual protein determinations in adults. Curr. Eye Res. 1982, 2:301-308.
40. Garcher C., Bron A., Baudouin C., Bildstein L., Bara J. CA 19-9 ELISA test: a new method for studying mucus changes in tears. Br. J. Ophthalmol. 1998, 82:88-90.
41. Gillette T.E., Allansmith M.R. Lactoferrin in human ocular tissues. Am. J. Ophthalmol. 1980, 90:30-37.
42. Glasgow B.J., Abduragimov A.R., Farahbakhsh Z.T., Faull K.F., Hubbell W.L. Tear lipocalins bind a broad array of lipid ligands. Curr. Eye Res. 1995, 14:363-372.
43. Glasgow B.J., Gasymov O.K. Focus on molecules: tear lipocalin. Exp. Eye Res. 2011, 92:242-243.
44. Glasgow B.J., Gasymov O.K., Abduragimov A.R., Engle J.J., Casey R.C. Tear lipocalin captures exogenous lipid from abnormal corneal surfaces. Invest. Ophthalmol. Vis. Sci. 2010, 51:1981-1987.
45. Gramlich O.W., Bell K., von Thun Und Hohenstein-Blaul N., Wilding C., Beck S., Pfeiffer N., Grus F.H. Autoimmune biomarkers in glaucoma patients. Curr. Opin. Pharmacol. 2013, 13:90-97.
46. Green-Church K.B., Butovich I., Willcox M., Borchman D., Paulsen F., Barabino S., Glasgow B.J. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest. Ophthalmol. Vis. Sci. 2011, 52:1979-1993.
47. Green-Church K.B., Nichols K.K., Kleinholz N.M., Zhang L., Nichols J.J. Investigation of the human tear film proteome using multiple proteomic approaches. Mol. Vis. 2008, 14:456-470.
48. Grus F.H., Augustin A.J. Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes. Electrophoresis 1999, 20:875-880.
49. Grus F.H., Augustin A.J. High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Eur. J. Ophthalmol. 2001, 11:19-24.
50. Grus F.H., Augustin A.J., Evangelou N.G., Toth-Sagi K. Analysis of tear-protein patterns as a diagnostic tool for the detection of dry eyes. Eur. J. Ophthalmol. 1998, 8:90-97.
51. Grus F.H., Boehm N., Beck S., Schlich M., Lossbrandt U., Pfeiffer N. Autoantibody profiles in tear fluid as a diagnostic tool in glaucoma. Invest. Ophthalmol. Vis. Sci. 2010, 51:6110.
52. Grus F.H., Boehm N., Berneiser S., Lamparter J., Wiegand M., Wiegel N., Pfeiffer N. Analysis of tear protein profiles in dry-eye patients by mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2009, 50:2546.
53. Grus F.H., Dick B., Augustin A.J., Pfeiffer N. Analysis of the antibody repertoire in tears of dry-eye patients. Ophthalmologica 2001, 215:430-434.
54. Grus F.H., Joachim S.C., Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin. Appl. 2007, 1:876-888.
55. Grus F.H., Kramann C., Bozkurt N., Wiegel N., Bruns K., Lackner N., Pfeiffer N. Effects of multipurpose contact lens solutions on the protein composition of the tear film. Cont. Lens Anterior Eye 2005, 28:103-112.
56. Grus F.H., Podust V.N., Bruns K., Lackner K., Fu S., Dalmasso E.A., Wirthlin A., Pfeiffer N. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest. Ophthalmol. Vis. Sci. 2005, 46:863-876.
57. Grus F.H., Sabuncuo P., Augustin A.J. Analysis of tear protein patterns of dry-eye patients using fluorescent staining dyes and two-dimensional quantification algorithms. Electrophoresis 2001, 22:1845-1850.
58. Grus F.H., Sabuncuo P., Augustin A.J. Quantitative analysis of tear protein profile for soft contact lenses-a clinical study. Klin. Monbl. Augenheilkd. 2001, 218:239-242.
59. Grus F.H., Sabuncuo P., Dick H.B., Augustin A.J., Pfeiffer N. Changes in the tear proteins of diabetic patients. BMC Ophthalmol. 2002, 2:4.
60. Grus F.H., Sabuncuo P., Herber S., Augustin A.J. Analysis of tear protein patterns for the diagnosis of dry eye. Adv. Exp. Med. Biol. 2002, 506:1213-1216.
61. Herber S., Grus F.H., Sabuncuo P., Augustin A.J. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001, 22:1838-1844.
62. Herber S., Grus F.H., Sabuncuo P., Augustin A.J. Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Adv. Exp. Med. Biol. 2002, 506:623-626.
63. Holopainen J.M., Moilanen J.A., Sorsa T., Kivela-Rajamaki M., Tervahartiala T., Vesaluoma M.H., Tervo T.M. Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 2003, 44:2550-2556.
64. Horn S., Lueking A., Murphy D., Staudt A., Gutjahr C., Schulte K., Konig A., Landsberger M., Lehrach H., Felix S.B., Cahill D.J. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics 2006, 6:605-613.
65. Hu S., Loo J.A., Wong D.T. Human body fluid proteome analysis. Proteomics 2006, 6:6326-6353.
66. Issaq H.J., Conrads T.P., Prieto D.A., Tirumalai R., Veenstra T.D. SELDI-TOF MS for diagnostic proteomics. Anal Chem. 2003, 75:148A-155A.
67. Janssen P.T., Van Bijsterveld O.P. Comparison of electrophoretic techniques for the analysis of human tear fluid proteins. Clin. Chim. Acta 1981, 114:207-218.
68. Kawai S., Nakajima T., Hokari S., Komoda T., Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Ann. Clin. Biochem. 2002, 39:56-61.
69. Kim H.J., Kim P.K., Yoo H.S., Kim C.W. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin. Biochem. 2012, 45:60-67.
70. Knop N., Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest. Ophthalmol. Vis. Sci. 2000, 41:1270-1279.
71. Koo B.S., Lee D.Y., Ha H.S., Kim J.C., Kim C.W. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J.Proteome Res. 2005, 4:719-724.
72. Kramann C., Boehm N., Lorenz K., Wehrwein N., Stoffelns B.M., Pfeiffer N., Grus F.H. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:233-243.
73. Kramann C.A., Pfeiffer N., Grus F. SELDI-TOF-MS ProteinChip Array Profiling of Tears from Dry-eye Patients: Diagnostic Applications of New Protein Biomarkers 2005, 2420.
74. Lam H., Bleiden L., de Paiva C.S., Farley W., Stern M.E., Pflugfelder S.C. Tear cytokine profiles in dysfunctional tear syndrome. Am. J. Ophthalmol. 2009, 147:198-205 e191.
75. Lebrecht A., Boehm D., Schmidt M., Koelbl H., Grus F.H. Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics 2009, 6:75-83.
76. Lebrecht A., Boehm D., Schmidt M., Koelbl H., Schwirz R.L., Grus F.H. Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics 2009, 6:177-182.
77. Lemp M.A. Report of the National eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995, 21:221-232.
78. Li G.Z., Vissers J.P., Silva J.C., Golick D., Gorenstein M.V., Geromanos S.J. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9:1696-1719.
79. Li K., Liu X., Chen Z., Huang Q., Wu K. Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis. Mol. Vis. 2010, 16:2084-2091.
80. Li N., Wang N., Zheng J., Liu X.M., Lever O.W., Erickson P.M., Li L. Characterization of human tear proteome using multiple proteomic analysis techniques. J.Proteome Res. 2005, 4:2052-2061.
81. Little J.M., Centifanto Y.M., Kaufman H.E. Immunoglobulins in human tears. Am. J. Ophthalmol. 1969, 68:898-905.
82. Liu J., Shi B., He S., Yao X., Willcox M.D., Zhao Z. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol. Vis. 2010, 16:2931-2938.
83. Lopilly Park H.Y., Kim J.H., Lee K.M., Park C.K. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp. Eye Res. 2012, 94:13-21.
84. Lu B., Motoyama A., Ruse C., Venable J., Yates J.R. Improving protein identification sensitivity by combining MS and MS/MS information for shotgun proteomics using LTQ-Orbitrap high mass accuracy data. Anal Chem. 2008, 80:2018-2025.
85. Maatta M., Kari O., Tervahartiala T., Peltonen S., Kari M., Saari M., Sorsa T. Tear fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:957-962.
86. Makarov A., Denisov E., Kholomeev A., Balschun W., Lange O., Strupat K., Horning S. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem. 2006, 78:2113-2120.
87. Malvitte L., Montange T., Vejux A., Baudouin C., Bron A.M., Creuzot-Garcher C., Lizard G. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br. J. Ophthalmol. 2007, 91:29-32.
88. Mandal N., Heegaard S., Prause J.U., Honore B., Vorum H. Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry. Biol. Proced Online 2009, 12:56-88.
89. Markoulli M., Papas E., Cole N., Holden B. Differential gel electrophoresis of the tear proteome. Optom. Vis. Sci. 2012, 89:E875-E883.
90. Massingale M.L., Li X., Vallabhajosyula M., Chen D., Wei Y., Asbell P.A. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009, 28:1023-1027.
91. Masson P.L., Heremans J.F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J.Exp. Med. 1969, 130:643-658.
92. Matheis N., Okrojek R., Grus F.H., Kahaly G.J. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid 2012, 22:1039-1045.
93. Mathers W.D., Stovall D., Lane J.A., Zimmerman M.B., Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998, 17:353-358.
94. McClellan B.H., Whitney C.R., Newman L.P., Allansmith M.R. Immunoglobulins in tears. Am. J. Ophthalmol. 1973, 76:89-101.
95. McGill J.I., Liakos G.M., Goulding N., Seal D.V. Normal tear protein profiles and age-related changes. Br. J. Ophthalmol. 1984, 68:316-320.
96. McHugh L., Arthur J.W. Computational methods for protein identification from mass spectrometry data. PLoS Comput. Biol. 2008, 4:e12.
97. Molloy M.P., Bolis S., Herbert B.R., Ou K., Tyler M.I., van Dyk D.D., Willcox M.D., Gooley A.A., Williams K.L., Morris C.A., Walsh B.J. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis 1997, 18:2811-2815.
98. Muller C., Schafer P., Stortzel M., Vogt S., Weinmann W. Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. J.Chromatogr. B Analyt Technol. Biomed. Life Sci. 2002, 773:47-52.
99. Nakamura Y., Sotozono C., Kinoshita S. Inflammatory cytokines in normal human tears. Curr. Eye Res. 1998, 17:673-676.
100. Nakanishi K., Sakiyama T., Imamura K. On the adsorption of proteins on solid surfaces, a common but very complicated phenomenon. J.Biosci. Bioeng. 2001, 91:233-244.
101. Narayanan S., Miller W.L., McDermott A.M. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest. Ophthalmol. Vis. Sci. 2006, 47:2445-2450.
102. Ng V., Cho P., Wong F., Chan Y. Variability of tear protein levels in normal young adults: diurnal (daytime) variation. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:257-263.
103. Ning K., Fermin D., Nesvizhskii A.I. Computational analysis of unassigned high-quality MS/MS spectra in proteomic data sets. Proteomics 2010, 10:2712-2718.
104. Ohashi Y., Ishida R., Kojima T., Goto E., Matsumoto Y., Watanabe K., Ishida N., Nakata K., Takeuchi T., Tsubota K. Abnormal protein profiles in tears with dry eye syndrome. Am. J. Ophthalmol. 2003, 136:291-299.
105. Okrojek R., Grus F.H., Matheis N., Kahaly G.J. Proteomics in autoimmune thyroid eye disease. Horm. Metab. Res. 2009, 41:465-470.
106. Pannebaker C., Chandler H.L., Nichols J.J. Tear proteomics in keratoconus. Mol. Vis. 2010, 16:1949-1957.
107. Park K.S., Kim S.S., Kim J.C., Kim H.C., Im Y.S., Ahn C.W., Lee H.K. Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am. J. Ophthalmol. 2008, 145:432-437.
108. Paulovich A.G., Whiteaker J.R., Hoofnagle A.N., Wang P. The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2008, 2:1386-1402.
109. Pere-Trepat E., Lacorte S., Tauler R. Solving liquid chromatography mass spectrometry coelution problems in the analysis of environmental samples by multivariate curve resolution. J.Chromatogr. A 2005, 1096:111-122.
110. Pflugfelder S.C., Jones D., Ji Z., Afonso A., Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 1999, 19:201-211.
111. Pieragostino D., Bucci S., Agnifili L., Fasanella V., D'Aguanno S., Mastropasqua A., Ciancaglini M., Mastropasqua L., Di Ilio C., Sacchetta P., Urbani A., Del Boccio P. Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma. Mol. Biosyst. 2012, 8:1017-1028.
112. Pietsch R.L., Pearlman M.E. Human tear lysozyme variables. Arch. Ophthalmol. 1973, 90:94-96.
113. Poyraz C., Irkec M., Mocan M.C. Elevated tear interleukin-6 and interleukin-8 levels associated with silicone hydrogel and conventional hydrogel contact lens wear. Eye Cont. Lens 2012, 38:146-149.
114. Redl B. Human tear lipocalin. Biochim. Biophys. Acta 2000, 1482:241-248.
115. Reitz C., Breipohl W., Augustin A., Bours J. Analysis of tear proteins by one- and two-dimensional thin-layer iosoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Graefes Arch. Clin. Exp. Ophthalmol. 1998, 236:894-899.
116. Remington S.G., Crow J.M., Nelson J.D. Antibodies to endogenous tear protein in normal human tears. Curr. Eye Res. 2009, 34:819-823.
117. Rifai N., Gillette M.A., Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24:971-983.
118. Robinson W.H., DiGennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., Fournel S., Fong D., Genovese M.C., de Vegvar H.E., Skriner K., Hirschberg D.L., Morris R.I., Muller S., Pruijn G.J., van Venrooij W.J., Smolen J.S., Brown P.O., Steinman L., Utz P.J. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8:295-301.
119. Rummenie V.T., Matsumoto Y., Dogru M., Wang Y., Hu Y., Ward S.K., Igarashi A., Wakamatsu T., Ibrahim O., Goto E., Luyten G., Inoue H., Saito I., Shimazaki J., Tsubota K. Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine 2008, 43:200-208.
120. Sack R., Conradi L., Beaton A., Sathe S., McNamara N., Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp. Eye Res. 2007, 85:528-538.
121. Sack R.A., Conradi L., Krumholz D., Beaton A., Sathe S., Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest. Ophthalmol. Vis. Sci. 2005, 46:1228-1238.
122. Sack R.A., Tan K.O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 1992, 33:626-640.
123. Sahu P.S., Parija S.C., Sahu P.K. Tear IgA-ELISA: a novel and sensitive method for diagnosis of ophthalmic cysticercosis. Acta Trop. 2008, 106:168-174.
124. Schirmer O. Studien zur Physiologie und Pathophysiologie der Tränenabsonderung und Tränenabfuhr. Albrecht von Graefes Arch. Opthalmol 1903, 56:197-291.
125. Schultz C.L., Kunert K.S. Interleukin-6 levels in tears of contact lens wearers. J.Interferon Cytokine Res. 2000, 20:309-310.
126. Seal D.V., McGill J.I., Mackie I.A., Liakos G.M., Jacobs P., Goulding N.J. Bacteriology and tear protein profiles of the dry eye. Br. J. Ophthalmol. 1986, 70:122-125.
127. Sen D.K., Sarin G.S. Immunoglobulin concentrations in human tears in ocular diseases. Br. J. Ophthalmol. 1979, 63:297-300.
128. Sen D.K., Sarin G.S., Mani K., Saha K. Immunoglobulins in tears of normal Indian people. Br. J. Ophthalmol. 1976, 60:302-304.
129. Shah C.A. Diabetic retinopathy: a comprehensive review. Indian J. Med. Sci. 2008, 62:500-519.
130. Sohal R.S. Role of oxidative stress and protein oxidation in the aging process. Free Radic. Biol. Med. 2002, 33:37-44.
131. Solomon A., Dursun D., Liu Z., Xie Y., Macri A., Pflugfelder S.C. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 2001, 42:2283-2292.
132. Soria J., Duran J.A., Etxebarria J., Merayo J., Gonzalez N., Reigada R., Garcia I., Acera A., Suarez T. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction. J.Proteomics 2012, 78C:94-112.
133. Sprung R., Chen Y., Zhang K., Cheng D., Zhang T., Peng J., Zhao Y. Identification and validation of eukaryotic aspartate and glutamate methylation in proteins. J.Proteome Res. 2008, 7:1001-1006.
134. Spurr-Michaud S., Argueso P., Gipson I. Assay of mucins in human tear fluid. Exp. Eye Res. 2007, 84:939-950.
135. Stapels M.D., Barofsky D.F. Complementary use of MALDI and ESI for the HPLC-MS/MS analysis of DNA-binding proteins. Anal Chem. 2004, 76:5423-5430.
136. Stapels M.D., Cho J.C., Giovannoni S.J., Barofsky D.F. Proteomic analysis of novel marine bacteria using MALDI and ESI mass spectrometry. J.Biomol. Tech. 2004, 15:191-198.
137. Sun L., McCormick A.V., Carr P.W. Study of the irreversible adsorption of proteins on polybutadiene-coated zirconia. J.Chromatogr. A 1994, 658:465-473.
138. Sviridov D., Meilinger B., Drake S.K., Hoehn G.T., Hortin G.L. Coelution of other proteins with albumin during size-exclusion HPLC: implications for analysis of urinary albumin. Clin. Chem. 2006, 52:389-397.
139. Tan S., Tan H.T., Chung M.C. Membrane proteins and membrane proteomics. Proteomics 2008, 8:3924-3932.
140. Tang H., Arnold R.J., Alves P., Xun Z., Clemmer D.E., Novotny M.V., Reilly J.P., Radivojac P. Acomputational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics 2006, 22:e481-488.
141. Thakur A., Willcox M.D. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp. Eye Res. 2000, 70:255-259.
142. Thiel U.J., Feltens R., Adryan B., Gieringer R., Brochhausen C., Schuon R., Fillies T., Grus F., Mann W.J., Brieger J. Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J.Oral Pathol. Med. 2011, 40:369-379.
143. Tishler M., Yaron I., Geyer O., Shirazi I., Naftaliev E., Yaron M. Elevated tear interleukin-6 levels in patients with Sjogren syndrome. Ophthalmology 1998, 105:2327-2329.
144. Toker E., Yavuz S., Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br. J. Ophthalmol. 2004, 88:384-387.
145. Tomosugi N., Kitagawa K., Takahashi N., Sugai S., Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J.Proteome Res. 2005, 4:820-825.
146. Tong L., Lee S.Y., Petznick A. Clinical considerations in proinflammatory cytokine profiling of tears from patients with dry eye by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2011, 52:9610. author reply 9610-9611.
147. Tsai P.S., Evans J.E., Green K.M., Sullivan R.M., Schaumberg D.A., Richards S.M., Dana M.R., Sullivan D.A. Proteomic analysis of human meibomian gland secretions. Br. J. Ophthalmol. 2006, 90:372-377.
148. Tsybikov N.N., Shovdra O.L., Prutkina E.V. The levels of endothelin, neuron-specific enolase, and their autoantibodies in the serum and tear fluid of patients with type 2 diabetes mellitus. Vestn Oftalmol. 2010, 126:14-16.
149. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
150. Van Haeringen N.J. Clinical biochemistry of tears. Surv. Ophthalmol. 1981, 26:84-96.
151. Witze E.S., Old W.M., Resing K.A., Ahn N.G. Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 2007, 4:798-806.
152. Wong T.T., Zhou L., Li J., Tong L., Zhao S.Z., Li X.R., Yu S.J., Koh S.K., Beuerman R.W. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest. Ophthalmol. Vis. Sci. 2011, 52:7385-7391.
153. Woo H.M., Bentley E., Campbell S.F., Marfurt C.F., Murphy C.J. Nerve growth factor and corneal wound healing in dogs. Exp. Eye Res. 2005, 80:633-642.
154. Wu C.C., Yates J.R. The application of mass spectrometry to membrane proteomics. Nat. Biotechnol. 2003, 21:262-267.
155. Wulfkuhle J.D., Paweletz C.P., Steeg P.S., Petricoin E.F., Liotta L. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv. Exp. Med. Biol. 2003, 532:59-68.
156. Yamada M., Mochizuki H., Kawai M., Tsubota K., Bryce T.J. Decreased tear lipocalin concentration in patients with meibomian gland dysfunction. Br. J. Ophthalmol. 2005, 89:803-805.
157. Yates J.R., Cociorva D., Liao L., Zabrouskov V. Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal Chem. 2006, 78:493-500.
158. Yavuz S., Toker E., Bicakcigil M., Mumcu G., Cakir S. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjogren's syndrome. J.Rheumatol. 2006, 33:1289-1292.
159. Yoon K.C., Jeong I.Y., Park Y.G., Yang S.Y. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 2007, 26:431-437.
160. You J., Fitzgerald A., Cozzi P.J., Zhao Z., Graham P., Russell P.J., Walsh B.J., Willcox M., Zhong L., Wasinger V., Li Y. Post-translation modification of proteins in tears. Electrophoresis 2010, 31:1853-1861.
161. You J., Hodge C., Wen L., McAvoy J.W., Madigan M.C., Sutton G. Tear levelsof SFRP1 are significantly reduced in keratoconus patients. Mol. Vis. 2013, 19:509-515.
162. Zhang T., Creek D.J., Barrett M.P., Blackburn G., Watson D.G. Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Anal Chem. 2012, 84:1994-2001.
163. Zhou L., Beuerman R.W. Tear analysis in ocular surface diseases. Prog. Retin. Eye Res. 2012 Nov, 31(6):527-550. (Epub 2012 Jun 23). 10.1016/j.preteyeres.2012.06.002.
164. Zhou L., Beuerman R.W., Ang L.P., Chan C.M., Li S.F., Chew F.T., Tan D.T. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest. Ophthalmol. Vis. Sci. 2009, 50:2077-2086.
165. Zhou L., Beuerman R.W., Chan C.M., Zhao S.Z., Li X.R., Yang H., Tong L., Liu S., Stern M.E., Tan D. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J.Proteome Res. 2009, 8:4889-4905.
166. Zhou L., Beuerman R.W., Foo Y., Liu S., Ang L.P., Tan D.T. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann. Acad. Med. Singapore 2006, 35:400-407.
167. Zhou L., Zhao S.Z., Koh S.K., Chen L., Vaz C., Tanavde V., Li X.R., Beuerman R.W. In-depth analysis of the human tear proteome. J.Proteomics 2012, 75:3877-3885.
168. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 2006, 82:885-898.